[8-(5-p-Methylphenyloxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-yl]carbamic acid tert-butyl ester → N1-[5-(4-Trifluoromethylphenyl)oxazol-2-yl]-5,6,7,8-tetrahydronaphthalene-1,7-diamine

HRID 600811

반응식

HRID 600811 반응식
C(OC(=O)[NH:7][CH:8]1[CH2:17][CH2:16][C:15]2[C:10](=[C:11]([NH:18][C:19]3[O:20][C:21]([C:24]4[CH:29]=[CH:28][C:27]([C:30]([F:33])([F:32])[F:31])=[CH:26][CH:25]=4)=[CH:22][N:23]=3)[CH:12]=[CH:13][CH:14]=2)[CH2:9]1)(C)(C)C.C(OC(=O)NC1CCC2C(=C(NC3OC(C4C=CC(C)=CC=4)=CN=3)C=CC=2)C1)(C)(C)C>>[F:33][C:30]([F:31])([F:32])[C:27]1[CH:28]=[CH:29][C:24]([C:21]2[O:20][C:19]([NH:18][C:11]3[C:10]4[CH2:9][CH:8]([NH2:7])[CH2:17][CH2:16][C:15]=4[CH:14]=[CH:13][CH:12]=3)=[N:23][CH:22]=2)=[CH:25][CH:26]=1

참가 물질

3

실험 절차

The title compound was prepared using the procedure as described in Example 20H substituting the product of Example 21A (120 mg, 0.253 mmol) for the product of Example 20G. The crude product was purified by trituration with Et2O/hexanes which resulted in 36 mg (38%) of the title compound as a white solid. 1H NMR (DMSO-d6) δ 9.32 (br s, 1H), 7.75 (m, 4H), 7.60 (s, 1H), 7.55 (d, J=7.8 Hz, 1H), 7.10 (t, J=7.8 Hz, 1H), 6.87 (d, J=7.8 Hz, 1H), 3.05-2.70 (m, 4H), 2.30 (m, 1H), 1.82 (m, 3H), 1.43 (m, 1H); MS (ESI+) m/z 374 (M+H)+.

후처리

  1. customThe title compound was prepared
  2. customThe crude product was purified by trituration with Et2O/hexanes which

출처 및 근거

ORD 기록
ord-a5842a9ab4ca4f219143e6336acb443a
출처 데이터셋
uspto-grants-2011_03
특허 번호
US07902236B2

연결된 노트

불러오는 중…